156 related articles for article (PubMed ID: 8578859)
1. The use of African horse sickness virus NS3 protein, expressed in bacteria, as a marker to differentiate infected from vaccinated horses.
Laviada MD; Roy P; Sánchez-Vizcaíno JM; Casal JI
Virus Res; 1995 Oct; 38(2-3):205-18. PubMed ID: 8578859
[TBL] [Abstract][Full Text] [Related]
2. African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform.
van Rijn PA; Maris-Veldhuis MA; Potgieter CA; van Gennip RGP
Vaccine; 2018 Apr; 36(15):1925-1933. PubMed ID: 29525278
[TBL] [Abstract][Full Text] [Related]
3. [Use of the immunoenzyme test ELISA-NS3 to distinguish horses infected by African horsesickness virus from vaccinated horses].
Idrissi Bougrine S; Fassi Fihri O; el Harrak M; Fassi Fehri MM
Rev Sci Tech; 1999 Dec; 18(3):618-26. PubMed ID: 10588005
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic DIVA tests accompanying the Disabled Infectious Single Animal (DISA) vaccine platform for African horse sickness.
van Rijn PA; Maris-Veldhuis MA; Boonstra J; van Gennip RGP
Vaccine; 2018 Jun; 36(25):3584-3592. PubMed ID: 29759377
[TBL] [Abstract][Full Text] [Related]
5. VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.
van de Water SG; van Gennip RG; Potgieter CA; Wright IM; van Rijn PA
J Virol; 2015 Sep; 89(17):8764-72. PubMed ID: 26063433
[TBL] [Abstract][Full Text] [Related]
6. The use of African horse sickness virus VP7 antigen, synthesised in bacteria, and anti-VP7 monoclonal antibodies in a competitive ELISA.
Wade-Evans AM; Woolhouse T; O'Hara R; Hamblin C
J Virol Methods; 1993 Dec; 45(2):179-88. PubMed ID: 8113344
[TBL] [Abstract][Full Text] [Related]
7. Western immunoblotting as a method for the detection of African horse sickness virus protein-specific antibodies: differentiation between infected and vaccinated horses.
Bougrine SI; Fihri OF; Fehri MM
Arch Virol Suppl; 1998; 14():329-36. PubMed ID: 9785518
[TBL] [Abstract][Full Text] [Related]
8. Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse sera.
Maree S; Paweska JT
J Virol Methods; 2005 Apr; 125(1):55-65. PubMed ID: 15737417
[TBL] [Abstract][Full Text] [Related]
9. Development of a Luminex-Based DIVA Assay for Serological Detection of African Horse Sickness Virus in Horses.
Sánchez-Matamoros A; Nieto-Pelegrín E; Beck C; Rivera-Arroyo B; Lecollinet S; Sailleau C; Zientara S; Sánchez-Vizcaíno JM
Transbound Emerg Dis; 2016 Aug; 63(4):353-9. PubMed ID: 27090377
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
Manning NM; Bachanek-Bankowska K; Mertens PPC; Castillo-Olivares J
Vaccine; 2017 Oct; 35(44):6024-6029. PubMed ID: 28438410
[TBL] [Abstract][Full Text] [Related]
11. African horse sickness virus serotype 4 antigens, VP1-1, VP2-2, VP4, VP7 and NS3, induce cytotoxic T cell responses in vitro.
Faber FE; van Kleef M; Tshilwane SI; Pretorius A
Virus Res; 2016 Jul; 220():12-20. PubMed ID: 27063332
[TBL] [Abstract][Full Text] [Related]
12. Use of reverse transcriptase-polymerase chain reaction (RT-PCR) and dot-blot hybridisation for the detection and identification of African horse sickness virus nucleic acids.
Zientara S; Sailleau C; Moulay S; Crucière C; el-Harrak M; Laegreid WW; Hamblin C
Arch Virol Suppl; 1998; 14():317-27. PubMed ID: 9785517
[TBL] [Abstract][Full Text] [Related]
13. Expression of nonstructural protein NS3 of African horsesickness virus (AHSV): evidence for a cytotoxic effect of NS3 in insect cells, and characterization of the gene products in AHSV infected Vero cells.
van Staden V; Stoltz MA; Huismans H
Arch Virol; 1995; 140(2):289-306. PubMed ID: 7710356
[TBL] [Abstract][Full Text] [Related]
14. Expression and characterization of the two outer capsid proteins of African horsesickness virus: the role of VP2 in virus neutralization.
Martinez-Torrecuadrada JL; Iwata H; Venteo A; Casal I; Roy P
Virology; 1994 Jul; 202(1):348-59. PubMed ID: 8009847
[TBL] [Abstract][Full Text] [Related]
15. Serological and virological responses in mules and donkeys following inoculation with African horse sickness virus serotype 4.
el Hasnaoui H; el Harrak M; Zientara S; Laviada M; Hamblin C
Arch Virol Suppl; 1998; 14():29-36. PubMed ID: 9785493
[TBL] [Abstract][Full Text] [Related]
16. Ns1 is a key protein in the vaccine composition to protect Ifnar(-/-) mice against infection with multiple serotypes of African horse sickness virus.
de la Poza F; Calvo-Pinilla E; López-Gil E; Marín-López A; Mateos F; Castillo-Olivares J; Lorenzo G; Ortego J
PLoS One; 2013; 8(7):e70197. PubMed ID: 23894615
[TBL] [Abstract][Full Text] [Related]
17. Passive transfer and rate of decay of maternal antibody against African horse sickness virus in South African Thoroughbred foals.
Crafford JE; Lourens CW; Gardner IA; Maclachlan NJ; Guthrie AJ
Equine Vet J; 2013 Sep; 45(5):604-7. PubMed ID: 23294121
[TBL] [Abstract][Full Text] [Related]
18. Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48h before, or 48h after challenge.
Calvo-Pinilla E; de la Poza F; Gubbins S; Mertens PP; Ortego J; Castillo-Olivares J
Antiviral Res; 2015 Apr; 116():27-33. PubMed ID: 25643968
[TBL] [Abstract][Full Text] [Related]
19. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus.
Guthrie AJ; Quan M; Lourens CW; Audonnet JC; Minke JM; Yao J; He L; Nordgren R; Gardner IA; Maclachlan NJ
Vaccine; 2009 Jul; 27(33):4434-8. PubMed ID: 19490959
[TBL] [Abstract][Full Text] [Related]
20. B-cell epitopes of African horse sickness virus serotype 4 recognised by immune horse sera.
Mathebula EM; Faber FE; Van Wyngaardt W; Van Schalkwyk A; Pretorius A; Fehrsen J
Onderstepoort J Vet Res; 2017 Feb; 84(1):e1-e12. PubMed ID: 28281773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
